Latest Mitral regurgitation Stories
A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition.
--Proceeds Will be Used To Fund New Initiative to Treat Mitral Valve Disease and to Complete Neovasc Reducer(TM) COSIRA Trial for Treating Refractory Angina-- TSX Venture Exchange: NVC VANCOUVER, July 21, 2011 /PRNewswire/ - Neovasc Inc.
STOUGHTON, Mass., July 20, 2011 /PRNewswire/ -- STD Med, Inc., a worldwide manufacturer and innovator of medical devices located in Stoughton, Massachusetts, is pleased to announce that one of its internally incubated medical device technologies, Spirus Medical, Inc., has been successfully acquired by Olympus Corporation.
Individuals with diastolic dysfunction (impaired relaxation of the heartâ€™s ventricle after contraction) appear to have increased risk of death, regardless of whether their systolic function (contraction of the ventricle) is normal or they have other cardiovascular impairments, according to this study.
An innovative approach for implanting a new aortic heart valve without open-heart surgery is being offered at Rush University Medical Center to patients with severe aortic stenosis who are at high-risk or not suitable candidates for open heart valve replacement surgery.